0

Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Coenzyme Q10 and Exercise Training Benefit Patients With Chronic Heart Failure

  • 작성자한진
  • 작성일2007-01-11 01:12:08
  • 조회수1804
  • 첨부파일첨부파일
NEW YORK (Reuters Health) Dec 29 - Oral coenzyme Q10 improves functional capacity, endothelial function, and left ventricular contractility in patients with chronic heart failure, according to a study in the November issue of the European Heart Journal. "Coenzyme Q10 (CoQ10), first isolated from beef heart mitochondria, is an essential component of the mitochondrial respiratory chain, and also has antioxidant properties," Dr. Romualdo Belardinelli, of Lancisi Heart Institute, Italy, and colleagues write. "However, its role in chronic heart failure (CHF) is not well defined." The study included 23 patients (mean age 59 years) with NYHA class II or III CHF secondary to ischemic heart disease (ejection fraction 37%). Patients were assigned to 4 weeks each of the following: oral CoQ10 (100 mg tid), CoQ10 plus supervised ET, (60% of peak VO2, 5 times/wk), placebo, and placebo plus ET. Of the 23 patients, 21 completed the study. No side effects were attributed to CoQ10. Supplementation with CoQ10 led to a four-fold increase in plasma CoQ10 level (from 0.82 mcg/mL to 3.64 mcg/mL, p < 0.0001). A significant decrease in plasma levels of uric acid (-3%, p < 0.0001) and a significant increase in HDL (+3%, p = 0.0588) were observed with CoQ10 supplementation. No significant changes in total cholesterol. LDL-C, triglycerides, and vitamin E levels were observed. CoQ10 treatment significantly improved peak VO2 (+9%, p = 0.0001). "Systolic wall thickening score index (SWTI) had similar improvements as EF both at rest and at peak dobutamine (-9% and -12%, respectively; p < 0.0001)," Dr. Belardinelli's team writes. "These improvements were related to changes in regional contractility." Patients treated with CoQ10 had significant improvements in the endothelium-dependent relaxation (+38%, p = 0.0021). Combining ET with oral CoQ10 was linked to more marked improvements in all parameters. "Oral CoQ10 improves functional capacity, endothelial function, and left ventricular contractility in CHF without any side effects," the authors conclude. Eur Heart J 2006;27:2675-2681.
Total406 [ page1/28 ]
No. 제목 작성자 작성일 조회수
406 한진, 김형규, 염재범 교수님과 함께한 2024 Spring Congress on Lipid and Atherosclerosis of KSOLA 춘계 학술대회 수상 2건 2024.04.18 작성자 2024.04.18 4
405 인제대 의과대학 김형규 교수, 생리학 분야 최고 학술상 수상 2023.11.09 관리자 2023.11.09 49
404 인제대, 과기정통부 ‘2023년도 기초연구실 지원사업’ 선정 2023.09.13 관리자 (web_admin) 2023.09.13 87
403 인제대 교수팀 '돌연사 주범 심부전 원인 규명' 2023.09.13 관리자 (web_admin) 2023.09.13 73
402 2022학년도 인제학술상 수상자 선정 결과 2023.01.05 관리자 2023.01.05 111
401 안전관리 우수연구실 인증 취득 2023.01.05 관리자 2023.01.05 65
400 한진교수 화의자의학상 수상 2023.01.05 관리자 2023.01.05 129
399 이온통로 학회 -Amy 포스터상 수상 2019.01.15 김형규 2019.01.15 2,603
398 센터 겸임교수 조성우 교수 - 한빛사 -JACC Vascular Imaging 2018.12.08 김형규 2018.12.08 2,816
397 2017 IMPACT Symposium 개최 첨부파일 2017.10.31 김보현 2017.10.31 2,603
396 경암바이오유스 2017 첨부파일 2017.08.11 김보현 2017.08.11 2,886
395 KORUS 2017 첨부파일 2017.06.21 김보현 2017.06.21 3,011
394 IMPACT 2016 심포지엄 개최 안내 첨부파일 2016.04.18 관리자 2016.04.18 4,021
393 IMPACT 2015 심포지엄 개최 안내 첨부파일 2015.04.20 서대윤 2015.04.20 2,881
392 2015 중점연구소 성과 전시회 첨부파일 2015.03.31 김형규 2015.03.31 2,473
처음이전1 2 3 4 5 6 7 8 9 10 다음 마지막